- Home
- OCCI vs DERM Comparison
OCCI vs DERM Comparison
Compare OCCI & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCCI
- DERM
- Stock Information
- Founded
- OCCI N/A
- DERM 2014
- Country
- OCCI United States
- DERM United States
- Employees
- OCCI N/A
- DERM N/A
- Industry
- OCCI Trusts Except Educational Religious and Charitable
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- OCCI Finance
- DERM Health Care
- Exchange
- OCCI Nasdaq
- DERM Nasdaq
- Market Cap
- OCCI 146.8M
- DERM 181.0M
- IPO Year
- OCCI N/A
- DERM 2021
- Fundamental
- Price
- OCCI $6.18
- DERM $8.06
- Analyst Decision
- OCCI
- DERM Strong Buy
- Analyst Count
- OCCI 0
- DERM 2
- Target Price
- OCCI N/A
- DERM $10.00
- AVG Volume (30 Days)
- OCCI 115.8K
- DERM 103.3K
- Earning Date
- OCCI 12-11-2023
- DERM 05-14-2025
- Dividend Yield
- OCCI 24.32%
- DERM N/A
- EPS Growth
- OCCI N/A
- DERM N/A
- EPS
- OCCI N/A
- DERM N/A
- Revenue
- OCCI N/A
- DERM $56,243,000.00
- Revenue This Year
- OCCI N/A
- DERM $29.83
- Revenue Next Year
- OCCI $10.19
- DERM $54.88
- P/E Ratio
- OCCI N/A
- DERM N/A
- Revenue Growth
- OCCI N/A
- DERM N/A
- 52 Week Low
- OCCI $5.47
- DERM $3.54
- 52 Week High
- OCCI $10.15
- DERM $8.24
- Technical
- Relative Strength Index (RSI)
- OCCI 42.48
- DERM 65.90
- Support Level
- OCCI $5.95
- DERM $6.55
- Resistance Level
- OCCI $6.82
- DERM $7.00
- Average True Range (ATR)
- OCCI 0.14
- DERM 0.63
- MACD
- OCCI -0.06
- DERM 0.13
- Stochastic Oscillator
- OCCI 28.09
- DERM 92.41
About OCCI OFS Credit Company Inc.
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.